20-13775263-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001276380.2(ESF1):c.1043G>A(p.Arg348His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000945 in 1,587,516 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001276380.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ESF1 | NM_001276380.2 | c.1043G>A | p.Arg348His | missense_variant | 4/14 | ENST00000617257.2 | NP_001263309.1 | |
ESF1 | NM_016649.4 | c.1043G>A | p.Arg348His | missense_variant | 4/14 | NP_057733.2 | ||
ESF1 | XM_017027874.3 | c.1043G>A | p.Arg348His | missense_variant | 4/14 | XP_016883363.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ESF1 | ENST00000617257.2 | c.1043G>A | p.Arg348His | missense_variant | 4/14 | 5 | NM_001276380.2 | ENSP00000480783 | P1 | |
ESF1 | ENST00000202816.5 | c.1043G>A | p.Arg348His | missense_variant | 4/14 | 5 | ENSP00000202816 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152088Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000251 AC: 6AN: 239398Hom.: 0 AF XY: 0.0000387 AC XY: 5AN XY: 129316
GnomAD4 exome AF: 0.00000766 AC: 11AN: 1435428Hom.: 0 Cov.: 27 AF XY: 0.0000140 AC XY: 10AN XY: 714830
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152088Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74292
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 26, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at